The benzene metabolite, hydroquinone and etoposide both induce endoreduplication in human lymphoblastoid TK6 cells.
暂无分享,去创建一个
[1] International System for Human Cytogenetic Nomenclature , 2020, Definitions.
[2] N. Pastor,et al. Tea flavanols inhibit cell growth and DNA topoisomerase II activity and induce endoreduplication in cultured Chinese hamster cells. , 2008, Mutation research.
[3] A. Smith,et al. Meta-analysis of benzene exposure and non-Hodgkin lymphoma: biases could mask an important association , 2008, Occupational and Environmental Medicine.
[4] J. Schwartz,et al. DNA Copy-Number Instability in Low-Dose Gamma-Irradiated TK6 Lymphoblastoid Clones , 2008, Radiation research.
[5] A. Hubbard,et al. Aberrations in chromosomes associated with lymphoma and therapy‐related leukemia in benzene‐exposed workers , 2007, Environmental and molecular mutagenesis.
[6] Martyn T. Smith,et al. Benzene Exposure and Risk of Non-Hodgkin Lymphoma , 2007, Cancer Epidemiology Biomarkers & Prevention.
[7] Alain Tremblay,et al. Nucleotide-resolution mapping of topoisomerase-mediated and apoptotic DNA strand scissions at or near an MLL translocation hotspot. , 2006, American journal of human genetics.
[8] D. Christiansen,et al. Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia , 2006, Leukemia.
[9] S. Mateos,et al. Topoisomerase II inhibition and high yield of endoreduplication induced by the flavonoids luteolin and quercetin. , 2006, Mutagenesis.
[10] A. Grosovsky,et al. Non-random distribution of instability-associated chromosomal rearrangement breakpoints in human lymphoblastoid cells. , 2006, Mutation research.
[11] S. Mateos,et al. Cisplatin-induced endoreduplication in CHO cells: DNA damage and inhibition of topoisomerase II. , 2006, Mutation research.
[12] A. Grosovsky,et al. Spontaneous and Radiation-Induced Genomic Instability in Human Cell Lines Differing in Cellular TP53 Status , 2005, Radiation research.
[13] P. Farmer,et al. Genotoxicity of the benzene metabolites para-benzoquinone and hydroquinone. , 2005, Chemico-biological interactions.
[14] D. Eastmond,et al. Topoisomerase II inhibition by myeloperoxidase-activated hydroquinone: a potential mechanism underlying the genotoxic and carcinogenic effects of benzene. , 2005, Chemico-biological interactions.
[15] A. Schnatter,et al. Review of the literature on benzene exposure and leukemia subtypes. , 2005, Chemico-biological interactions.
[16] N. Rothman,et al. Use of OctoChrome fluorescence in situ hybridization to detect specific aneuploidy among all 24 chromosomes in benzene-exposed workers. , 2005, Chemico-biological interactions.
[17] C. Campanella,et al. Endoreduplication induced in cultured Chinese hamster cells by different anti-topoisomerase II chemicals. Evidence for the essential contribution of the enzyme to chromosome segregation. , 2005, Mutation research.
[18] N. Osheroff,et al. Effects of benzene metabolites on DNA cleavage mediated by human topoisomerase II alpha: 1,4-hydroquinone is a topoisomerase II poison. , 2005, Chemical research in toxicology.
[19] S. Mateos,et al. Toward a comprehensive model for induced endoreduplication. , 2004, Life sciences.
[20] H. Liber,et al. Baseline levels of chromosome instability in the human lymphoblastoid cell TK6. , 2004, Mutagenesis.
[21] R. Snyder,et al. Inhibition of topoisomerase II in 32D.3(G) cells by hydroquinone is associated with cell death , 2004, Journal of applied toxicology : JAT.
[22] JAMES C. Wang,et al. Cellular roles of DNA topoisomerases: a molecular perspective , 2002, Nature Reviews Molecular Cell Biology.
[23] S. Mateos,et al. High yield of endoreduplication induced by ICRF-193: a topoisomerase II catalytic inhibitor. , 2002, Mutation research.
[24] M. Slovak,et al. 21q22 balanced chromosome aberrations in therapy‐related hematopoietic disorders: Report from an International Workshop † , 2002, Genes, chromosomes & cancer.
[25] C. Bloomfield,et al. 11q23 balanced chromosome aberrations in treatment‐related myelodysplastic syndromes and acute leukemia: Report from an International Workshop † , 2002, Genes, chromosomes & cancer.
[26] D. Eastmond,et al. The Nature of Chromosomal Aberrations Detected in Humans Exposed to Benzene , 2002, Critical reviews in toxicology.
[27] R. Hayes,et al. Benzene and lymphohematopoietic malignancies in humans. , 2001, American journal of industrial medicine.
[28] D. Pyatt,et al. Benzene metabolites antagonize etoposide-stabilized cleavable complexes of DNA topoisomerase IIalpha. , 2001, Blood.
[29] B. Edgar,et al. Endoreplication Cell Cycles More for Less , 2001, Cell.
[30] C. Felix. Leukemias related to treatment with DNA topoisomerase II inhibitors. , 2001, Medical and pediatric oncology.
[31] D. Ross,et al. THE ROLE OF METABOLISM AND SPECIFIC METABOLITES IN BENZENE-INDUCED TOXICITY: EVIDENCE AND ISSUES , 2000, Journal of toxicology and environmental health. Part A.
[32] C. Chevalier,et al. Endoreduplication in higher plants , 2000, Plant Molecular Biology.
[33] Sanjeev Gupta,et al. Partial hepatectomy-induced polyploidy attenuates hepatocyte replication and activates cell aging events. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[34] A. T. Sumner. Induction of diplochromosomes in mammalian cells by inhibitors of topoisomerase II , 1998, Chromosoma.
[35] R. Hayes,et al. Increased aneusomy and long arm deletion of chromosomes 5 and 7 in the lymphocytes of Chinese workers exposed to benzene. , 1998, Carcinogenesis.
[36] C. Felix. Secondary leukemias induced by topoisomerase-targeted drugs. , 1998, Biochimica et biophysica acta.
[37] R. Hayes,et al. Increased translocations and aneusomy in chromosomes 8 and 21 among workers exposed to benzene. , 1998, Cancer research.
[38] Luoping Zhang,et al. Benzene metabolites induce the loss and long arm deletion of chromosomes 5 and 7 in human lymphocytes. , 1998, Leukemia research.
[39] G. Kalf,et al. Inhibition of human DNA topoisomerase II by hydroquinone and p-benzoquinone, reactive metabolites of benzene. , 1996, Environmental health perspectives.
[40] Y. Hiraku,et al. Oxidative DNA damage and apoptosis induced by benzene metabolites. , 1996, Cancer research.
[41] F. Mitelman. International standing committee on human cytogenetic nomenclature , 1996 .
[42] M. Wallin,et al. Effects of potential aneuploidy inducing agents on microtubule assembly in vitro. , 1993, Mutation research.
[43] J. Pedersen‐Bjergaard,et al. Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II [letter] , 1991 .
[44] D. Eastmond,et al. Two benzene metabolites, catechol and hydroquinone, produce a synergistic induction of micronuclei and toxicity in cultured human lymphocytes. , 1991, Mutation research.
[45] W. Bodell,et al. Detection of DNA adducts in HL-60 cells treated with hydroquinone and p-benzoquinone by 32P-postlabeling. , 1991, Carcinogenesis.
[46] Martyn T. Smith,et al. Characterization of micronuclei induced in human lymphocytes by benzene metabolites. , 1990, Cancer research.
[47] J. Blumer,et al. Relationship between the oxidation potential of benzene metabolites and their inhibitory effect on DNA synthesis in L5178YS cells. , 1985, Molecular pharmacology.
[48] R. Irons,et al. Effects of the principal hydroxy-metabolites of benzene on microtubule polymerization , 1980, Archives of Toxicology.
[49] A. Levan,et al. Endomitotic reduplication mechanisms in ascites tumors of the mouse. , 1953, Journal of the National Cancer Institute.
[50] A. Hubbard,et al. Nonrandom aneuploidy of chromosomes 1, 5, 6, 7, 8, 9, 11, 12, and 21 induced by the benzene metabolites hydroquinone and benzenetriol , 2005, Environmental and molecular mutagenesis.
[51] L. Larizza,et al. Somatic cell fusion as a source of genetic rearrangement leading to metastatic variants , 2004, Cancer and Metastasis Reviews.
[52] Nuria Pastor,et al. ICRF-193が誘発する高い量の核内倍加 トポイソメラーゼII接触阻害剤 , 2002 .
[53] VP Etoposide. DNA topoisomerase II inhibitors. , 2000, IARC monographs on the evaluation of carcinogenic risks to humans.
[54] E. Zybina,et al. Trophoblast cell invasiveness and capability for the cell and genome reproduction in rat placenta. , 2000, Early pregnancy.
[55] Y. Pommier. DNA Topoisomerase II Inhibitors , 1997 .
[56] Luoping Zhang,et al. Benzene metabolite, 1,2,4‐benzenetriol, induces micronuclei and oxidative DNA damage in human lymphocytes and HL60 cells , 1993, Environmental and molecular mutagenesis.
[57] J. Pedersen‐Bjergaard,et al. Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II. , 1991, Blood.
[58] H. Takanari,et al. Studies on endoreduplication. II. Spontaneous occurrence and cellular kinetics of endoreduplication in PHA-stimulated tonsillar lymphocytes. , 1981, Cytogenetics and Cell Genetics.
[59] H. Takanari,et al. Studies on endoreduplication , 1981 .
[60] Y. Rumpler,et al. International Standing Committee on Human Cytogenetic Nomenclature , 1976 .
[61] J. Higginson. International Agency for Research on Cancer. , 1968, WHO chronicle.